Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROPHY: Candesartan for Hypertension Prevention
NCT00227318Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 1998
- Primary completion
- Oct 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in hypertension (HTN), sponsored by AstraZeneca. Started Jul 1998; status: completed.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00227318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227318.